UNITAID’s approach to transform health product markets has delivered price reductions of up to 80% for HIV/AIDS, tuberculosis and malaria medicines and diagnostics for the world’s poor, according to Results Beyond Investment, its 2012 Annual Report just released.
Selon UNITAID, après d’importants résultats obtenus dans la lutte contre le paludisme ces dix dernières années, l’action à venir doit être encore mieux ciblée pour que ces progrès soient maintenus.
Following the significant gains in the fight against malaria over the past decade, future efforts must be more targeted if progress is to be maintained, UNITAID warns.
Boulder Diagnostics Inc. announced today the European market launch of its ParaFlor™ kits for the detection of Giardia, Cryptosporidium and Blastocystis infections for human and veterinary applications.
Up to £190 million of savings could potentially be made to the UK’s health and social care costs without compromising services to service users, according to a leading firm of consultants.
Lors d’une rencontre avec Philippe Douste-Blazy, président du Conseil d’administration d’UNITAID et conseiller spécial auprès du Secrétaire général des Nations Unies en charge des financements innovants pour le développement, et le représentant de l’Alliance des dirigeants africains contre le paludisme (ALMA), le ministère des Finances du Mozambique a confirmé la volonté du pays de mettre en place une taxe modique sur les billets d’avion ainsi que sur les transactions financières afin de récolter des fonds supplémentaires pour la lutte contre le VIH/sida, la tuberculose et le paludisme.
During a meeting with Philippe Douste-Blazy, Chair of the Executive Board of UNITAID and Special Advisor to the Secretary General of the United Nations on Innovative Financing for Development, and a representative of the African Leaders Malaria Alliance, the administration of the Minister of Finance, Mozambique, confirmed the country’s commitment to implement both a small levy on air ticket sales and financial transactions to raise additional funding to fight HIV/AIDS, tuberculosis and malaria.
Dr Victor Chua and Adam Scott announce today the establishment of a new partnership, Mansfield Advisors LLP, focusing on strategy consulting to NHS and private hospitals, elderly and social care, and medical technology.